Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)
Status:
Withdrawn
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
The project was organized by Qilu Hospital of Shandong University in China. In order to
report the efficacy and safety of different cycles of high-dose dexamethasone for the
treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).